Spectrum Pharma (SPPI) Reports Q3 EPS of $0.00

Spectrum Pharma (NASDAQ: SPPI) reported Q3 revenues of $33.4 million versus the consensus estimate of $28.43 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BNP Paribas Exane Downgrades Lanxess AG (LXS:GR) (LNXSF) to Underperform